On the other hand, TST003 significantly decreases tumor cell proliferation and spheroid formation capacity by inhibiting the FGFR1/MAPK signaling axis, demonstrating potential antitumor activity in various refractory solid tumor models (15). This evidence concerns the gene FGFR1 and neoplasm.